Vita Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$31M
- Investors
-
12
Vita Therapeutics General Information
Description
Operator of a cellular therapeutics and cell engineering company intended for the treatment of debilitating neuromuscular diseases and cancers. The company's treatments utilize induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients, enabling clinicians to address the root cause of diseases using truly curative cellular medicines.
Contact Information
Website
www.vitatx.comCorporate Office
- 801 West Baltimore Street
- Suite 301
- Baltimore, MD 21201
- United States
Corporate Office
- 801 West Baltimore Street
- Suite 301
- Baltimore, MD 21201
- United States
Vita Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series B) | 12-Oct-2022 | $31M | Completed | Pre-Clinical Trials | ||
| 5. Early Stage VC (Series A) | 23-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 26-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 05-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 16-Jul-2019 | Completed | Pre-Clinical Trials | |||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Vita Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 7,684,599 | $0.001000 | $1 | $1 | 1x | $1 | 12.44% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Vita Therapeutics Comparisons
Industry
Financing
Details
Vita Therapeutics Competitors (2)
One of Vita Therapeutics’s 2 competitors is NMD Pharma, a Venture Capital-Backed company based in Aarhus, Denmark.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NMD Pharma | Venture Capital-Backed | Aarhus, Denmark | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA |
Vita Therapeutics Patents
Vita Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026207168-A1 | Adeno-associated virus (aav) vector for delivery to muscle cells | Pending | 25-Mar-2025 | ||
| US-20260009003-A1 | Manufacturing of therapeutic satellite cells for treating muscular dystrophy | Pending | 11-Jul-2022 | ||
| WO-2024015329-A1 | Manufacturing of therapeutic satellite cells for treating muscular dystrophy | Inactive | 11-Jul-2022 | ||
| EP-4436615-A1 | Immune cell therapy of pd-l1 positive cancers | Inactive | 26-Nov-2021 | ||
| US-20250009880-A1 | Immune cell therapy of pd-l1 positive cancers | Pending | 26-Nov-2021 | A61K40/31 |
Vita Therapeutics Signals
Vita Therapeutics Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abell Foundation | Not-For-Profit Venture Capital | Minority | ||
| Cedars-Sinai | Corporation | Minority | ||
| Riptide Ventures | Angel Group | Minority | ||
| Solve FSHD | Not-For-Profit Venture Capital | Minority | ||
| Cambrian Bio | VC-Backed Company | Minority |
Vita Therapeutics FAQs
-
When was Vita Therapeutics founded?
Vita Therapeutics was founded in 2019.
-
Where is Vita Therapeutics headquartered?
Vita Therapeutics is headquartered in Baltimore, MD.
-
What is the size of Vita Therapeutics?
Vita Therapeutics has 9 total employees.
-
What industry is Vita Therapeutics in?
Vita Therapeutics’s primary industry is Drug Discovery.
-
Is Vita Therapeutics a private or public company?
Vita Therapeutics is a Private company.
-
What is Vita Therapeutics’s current revenue?
The current revenue for Vita Therapeutics is .
-
How much funding has Vita Therapeutics raised over time?
Vita Therapeutics has raised $65.7M.
-
Who are Vita Therapeutics’s investors?
Abell Foundation, Cedars-Sinai, Riptide Ventures, Solve FSHD, and Cambrian Bio are 5 of 12 investors who have invested in Vita Therapeutics.
-
Who are Vita Therapeutics’s competitors?
NMD Pharma and Sarepta Therapeutics are competitors of Vita Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process